Healthcare Exec/Investor. Current T.🦖x Capital. Fmr CE🍐 of #Pear_Tx. 🦄recovering physician-neuroscientist-McK consultant. 🤵🏼fantasy football commissioner.
Our prescription digital therapeutics (#PDTs) for the treatment of substance use and opioid use disorders are now available to Florida Medicaid members. Learn how this coverage decision helps put care in the hands of people in recovery.
Scoop from me: A large insurer bites the bullet and says it intends to cover software-based treatments that have been cleared by the FDA.
Big news for developers of so-called prescription digital therapeutics. https://t.co/XkR3EiHJmR
#PDTs could revolutionize mental health care in America. In this Op-Ed, @PJK4brainhealth and Paul Mango discuss the urgent need for passing the bipartisan Access to Prescription Digital Therapeutics Act of 2022 to expand treatment access for millions of Americans.
#ICYMI: We shared new data at #APAAM22 showing our prescription digital therapeutic (#PDT) for opioid use disorder generated similar levels of engagement across a broad range of environments, from rural to urban. Learn more about this data and how #PDTs can reduce gaps in care.
We are proud to share that new research on brain-wide association studies led by co-founders @ndosenbach and @DrDamienFair has been published in @Nature. Learn more about their findings: https://t.co/EMTKqtJ96o
Today, @SenatorShaheen, @RepMcKinley, @RepThompson and I introduced a bill that would give more Americans access to the innovative, digital therapeutics treatments they need and deserve.
This is — and I can’t stress this enough — the greatest segment to come from a sports broadcast that I have ever seen in my entire life https://t.co/H8sBOZzbhX
Congratulations to first author Samyukta Karthik! And many thank/ to our lab-mates and collaborators.
@Corey_M_McCann, it would have made Arthur smile to see you on the author list.
IMO mental health companies are overly fixated on distribution (e.g. going through employer channels) than changing the core of the problem - we don't have enough supply (clinicians) to meet demand or good ways to measure patient progress
We’re proud to work with Michigan to provide Michiganders with access to prescription digital therapeutics (#PDTs) for the safe and effective treatment of substance use and opioid use disorders. Read more:
Nico Dosenbach, MD, PhD, scanned his 13-year-old patient in 2012 and found he had suffered a massive perinatal stroke and lost large parts of his brain. Defying logic, Daniel's now an athletic college graduate. Read more in @washingtonpost: https://t.co/a2lZYoNRN3 #MIRpatientcare
As part of our commitment to reducing barriers to care, we’re excited to collaborate with @ok_hca to provide Oklahomans in recovery with access to our prescription digital therapeutics (#PDTs) for substance use disorder and opioid use disorder. Learn more about the agreement.
Today, our CEO @corey_m_mccann virtually rang the Closing Bell in honor of our @NASDAQ listing and shared his thoughts on what this milestone means for $PEAR, and more importantly, for the potential transformation of healthcare via software-based medicines.